Records 1 - 1 (of 1 Records) |
Query Trace: Global Health Network Preprints[original query] |
---|
Effectiveness of COVID-19 vaccines against hospital admission with the Delta (B.1.617.2) variant
Stowe, Julia et al. Global Health Network Preprints 2021
Summary:
Between April 12 and June 4, 2021 there were 14,019 symptomatic cases of SARS-CoV-2 B.1.617.2 variant with 166 hospitalizations in England. Vaccine effectiveness of 1 or 2 doses of BNT162b2 (Pfizer/BioNTech) or of 2 doses of ChAdOx1 (Oxford/AstraZeneca) against hospitalization with the B.1.617.2 variant was >90% and was comparable to effectiveness against hospitalization with the B.1.1.7 variant.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Disclaimer: The purpose of the CDC COVID-19 Science
Update is to share public health articles with public health agencies
and departments for informational and educational purposes. Materials
listed in this Science Update are selected to provide awareness of
relevant public health literature. A material’s inclusion and the
material itself provided here in full or in part, does not necessarily
represent the views of the U.S. Department of Health and Human
Services or the CDC, nor does it necessarily imply endorsement of
methods or findings. While much of the COVID-19 literature is open
access or otherwise freely available, it is the responsibility of the
third-party user to determine whether any intellectual property rights
govern the use of materials in this Science Update prior to use or
distribution. Findings are based on research available at the time of
this publication and may be subject to change.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 03, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure